AAAAAA
Results:
1-14
|
Results: 14
Authors:
Martin, K
Heinzlmann, M
Borchers, R
Mack, M
Loeschke, K
Folwaczny, C
Citation: K. Martin et al., Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease, CLIN IMMUNO, 98(1), 2001, pp. 18-22
Authors:
Schafer, M
Schmidt, F
Grunze, H
Laakmann, G
Loeschke, K
Citation: M. Schafer et al., Interferon-alpha associated with agranulocytosis during medication with clozapine, NERVENARZT, 72(11), 2001, pp. 872-875
Authors:
Folwaczny, C
Born, C
Loeschke, K
Citation: C. Folwaczny et al., Closure of an enterocutaneous fistula by high dose intravenous immune globuline therapy in a patient with X-linked agammaglobulinemia, AM J GASTRO, 96(6), 2001, pp. 1954-1955
Authors:
Folwaczny, C
Loeschke, K
Schnettler, D
Jager, G
Wiebecke, B
Hoelscher, M
Sauer, T
Konig, A
Endres, SP
Fricke, H
Citation: C. Folwaczny et al., Endothelial cell autoantibodies are a marker of disease susceptibility in inflammatory bowel disease but apparently not linked to persistent measles virus infection, CLIN IMMUNO, 95(3), 2000, pp. 197-202
Authors:
Grasberger, H
Otto, B
Loeschke, K
Citation: H. Grasberger et al., Ceftriaxone-associated nephrolithiasis, ANN PHARMAC, 34(9), 2000, pp. 1076-1077
Authors:
Schafer, M
Schmidt, F
Amann, B
Schlosser, S
Loeschke, K
Grunze, H
Citation: M. Schafer et al., Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis, NEUROPSYCHB, 42, 2000, pp. 43-45
Authors:
Fellermann, K
Steffen, M
Stein, J
Raedler, A
Hamling, J
Ludwig, D
Loeschke, K
Stange, EF
Citation: K. Fellermann et al., Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease, ALIM PHARM, 14(2), 2000, pp. 171-176
Authors:
Voderholzer, WA
Zietz, C
Feucht, HE
Heldwein, W
Hallfeldt, H
Huber, RM
Loeschke, K
Citation: Wa. Voderholzer et al., Gastric outlet obstruction and pulmonary infiltrate in a patient with Crohn's disease: Successful treatment by Billroth-II-resection, Z GASTROENT, 38(8), 2000, pp. 637-641
Authors:
Siegmund, B
Folwaczny, C
Bader, L
Otto, B
Hoelscher, M
Leinsinger, G
Herzer, P
Loeschke, K
Citation: B. Siegmund et al., Staphylococcal pyomyositis with tuberculosis, hepatitis-B and renal insufficiency, INTERNIST, 41(9), 2000, pp. 903-907
Authors:
Folwaczny, C
Zahn, R
Brunnler, G
Albert, E
Koenig, A
Noehl, N
Loeschke, K
Fricke, H
Citation: C. Folwaczny et al., Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis, Z GASTROENT, 37(2), 1999, pp. 133-140
Authors:
Lang, SM
Stratakis, DF
Heinzlmann, M
Heldwein, W
Wiebecke, B
Loeschke, K
Citation: Sm. Lang et al., Molecular screening of patients with long standing extensive ulcerative colitis: detection of p53 and Ki-ras mutations by single strand conformation polymorphism analysis and differential hybridisation in colonic lavage fluid, GUT, 44(6), 1999, pp. 822-825
Authors:
Folwaczny, C
Jager, G
Schnettler, D
Wiebecke, B
Loeschke, K
Citation: C. Folwaczny et al., Search for mumps virus genome in intestinal biopsy specimens of patients with IBD, GASTROENTY, 117(5), 1999, pp. 1253-1254
Authors:
Spannagi, M
Dick, A
Folwaczny, C
Schramm, W
Loeschke, K
Citation: M. Spannagi et al., Factor V Leiden mutation in patients with inflammatory bowel disease, GASTROENTY, 117(1), 1999, pp. 280-280
Authors:
Folwaczny, C
Wiebecke, B
Loeschke, K
Citation: C. Folwaczny et al., Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease, AM J GASTRO, 94(6), 1999, pp. 1551-1555
Risultati:
1-14
|